Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Pulmonary Embolism Blood Tests Reduce Radiation Exposure

By MedImaging International staff writers
Posted on 24 Dec 2019
A new study suggests that D-dimer blood tests can help rule out pulmonary embolism (PE), reducing the need for a diagnostic computerized tomography (CT) scan.

Researchers at McMaster University (Hamilton, ON, Canada), the University of Alberta (Edmonton, Canada), McGill University (Montreal, Canada), and other institutions conducted a prospective study involving 2,017 adult (average age 52 years, 66% female), of whom 7.4% had PE on initial diagnostic testing. More...
PE was considered to be ruled out without further testing in outpatients with a low clinical pretest probability (C-PTP) and a D-dimer level of less than 1000 ng per milliliter, or with a moderate C-PTP and a D-dimer level of less than 500 ng per milliliter.

All other suspected patients underwent chest imaging (usually CT pulmonary angiography); if PE was not diagnosed, the patients did not receive anticoagulant therapy. All patients were followed for 3 months to detect venous thromboembolism (VTE). The results revealed that none of patients who were ruled out based on C-PTP and d-dimer levels had VTE at follow-up. Of 1,863 patients who did not receive a diagnosis of PE initially, and did not receive anticoagulant therapy, one patient had VTE. The study was published on November 27, 2019, in the New England Journal of Medicine (NEJM).

“When a physician is concerned that PE may be present, chest imaging with CT pulmonary angiography is usually done in half of these patients. We wanted to find a way to reduce the number of CT scans that need to be done,” concluded lead author Professor Clive Kearon, MB, PhD, of McMaster University. “Our diagnostic strategy resulted in the use of chest imaging in 34.3% of patients, whereas a strategy in which PE is considered to be ruled out with a low C-PTP and a d-dimer level of less than 500 ng per milliliter would result in the use of chest imaging in 51.9%. This way of using D-dimer testing and clinical assessment reduced the need for CT scanning by one-third.”

D-dimer is a fibrin degradation product. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link. Since its introduction in the 1990s, it has become an important test for patients with suspected thrombotic disorders. While a negative result practically rules out thrombosis, a positive result can indicate thrombosis, but does not rule out other potential causes. Its main use, therefore, is to exclude thromboembolic disease where the probability is low.

Related Links:
McMaster University
University of Alberta
McGill University



Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Pocket Fetal Doppler
CONTEC10C/CL
Digital Radiographic System
OMNERA 300M
40/80-Slice CT System
uCT 528
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.